QUANTUM BIOPHAR (QNTM)
(Real Time Quote from BATS)
$24.55 USD
-0.02 (-0.08%)
Updated Aug 6, 2025 11:40 AM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Quantum Biopharma Ltd. has a market cap of $71.44M, which represents its share price of $24.57 multiplied by its outstanding shares number of 2.91M. As a small-cap company, QNTM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
QNTM 24.55 -0.02(-0.08%)
Will QNTM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QNTM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QNTM
QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know
QNTM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for QNTM
Quantum BioPharma (QNTM) Advances Lucid-MS Development Following Positive Trial
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 ...
Quantum Group subsidiary received CSR for Phase 1 MAD trial
Quantum BioPharma (QNTM) Counters Motion to Dismiss in Market Manipulation Case
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, ...